Kisspeptin has picked up some dramatic nicknames: the "sex drive peptide," the "master switch," the hormone of desire. Unusually for this category, the nicknames are not invented from nothing. They trace back to real, well-designed human studies. They also skip over the details that matter most. This guide explains what kisspeptin is, why it earned its reputation, and what the research actually tested.
The short answer
Kisspeptin is a natural brain hormone that sits at the very top of the chain controlling reproduction. Without it, puberty does not start. It earned the "master switch" name because every other reproductive hormone waits for its signal. It earned the "sex drive" name because brain-imaging studies at Imperial College London found it changed activity in the brain's sexual and emotional processing areas. Those studies used a longer form of the molecule, given by intravenous drip in a hospital setting, which is an important detail most retellings leave out.
A name from a chocolate factory town
Kisspeptin was discovered in 1996 by researchers in Hershey, Pennsylvania, home of the chocolate company. They were studying why some skin-cancer cells spread and others did not, and found a gene that appeared to hold spread in check. They named it KiSS-1, a nod to the town's famous Hershey's Kisses.
For several years, that was the whole story: a cancer-research gene. Nobody suspected it had anything to do with reproduction.
How it became the "master switch"
In 2003, two research groups independently studied families in which some members never went through puberty. Both traced the cause to faults in the same gene: the receptor that kisspeptin binds to. Mice bred without that receptor showed the same thing. The conclusion was striking. Without a working kisspeptin signal, the reproductive system never switches on.
To see why, it helps to picture the reproductive system as a chain of command.
- Kisspeptin, released by nerve cells deep in the brain's hypothalamus, gives the first order.
- GnRH, a hormone released next door, responds to that order.
- The pituitary gland, at the base of the brain, answers GnRH by releasing two hormones, LH and FSH, into the blood.
- The testes or ovaries answer LH and FSH by producing sperm or eggs, and sex hormones such as testosterone and estrogen.
Scientists call this chain the reproductive axis. For decades GnRH was considered the top of it. Kisspeptin turned out to sit one step higher, acting as the upstream regulator that tells GnRH when, and how often, to fire. That is why it is called the master switch.
The timing matters as much as the signal. GnRH is released in pulses, like a metronome, and the rhythm of those pulses carries information. A specialized group of kisspeptin-producing nerve cells is now thought to be the core of that metronome.
Where the "sex drive" reputation comes from
Most hormones in the reproductive chain act on the body. Kisspeptin also has receptors in parts of the brain involved in emotion, reward and motivation, including the limbic system. That raised an obvious question: does it influence how the brain processes sexual and emotional information?
A research group at Imperial College London, led by endocrinologists Waljit Dhillo and Alexander Comninos, set out to test it in people.
2017, healthy young men. Twenty-nine men received either kisspeptin or a placebo on separate visits, without knowing which, while viewing images in a brain scanner. With kisspeptin, activity in limbic brain regions rose specifically in response to sexual images and to non-sexual images of couples, and participants reported less negative mood. This is the origin of the "emotional and sexual processor" description.
2023, men and women with low sexual desire. Two further trials, published in JAMA Network Open, studied 32 men and 32 premenopausal women diagnosed with hypoactive sexual desire disorder, a condition defined by persistently low desire that causes distress. Again using a placebo-controlled crossover design, both trials found kisspeptin changed activity in brain regions involved in sexual processing. In the men's study, measured physical arousal responses to a video were also higher than with placebo.
Put together, these studies are the reason for the nickname. They are careful, placebo-controlled human research, which is more than most peptides in this category can point to.
What the headlines leave out
The studies used kisspeptin-54, not kisspeptin-10. The body makes kisspeptin in several lengths. The version used in the Imperial brain-imaging studies is 54 amino acids long. Kisspeptin-10, the form most commonly sold for research, is the final ten amino acids of that chain. Both activate the same receptor, but they behave differently: kisspeptin-10 is cleared from the blood within minutes, while kisspeptin-54 lasts considerably longer. Findings for one form do not automatically transfer to the other.
The delivery was a hospital drip. In every one of these trials, kisspeptin was given as a controlled intravenous infusion over about 75 minutes, under medical supervision.
Each was a single session. The trials measured what happened during one visit. What happens with repeated exposure over weeks or months has not been tested in these studies.
Brain activity is not behavior. A change on a brain scan shows that kisspeptin influences how certain information is processed. It is a strong clue, not a demonstration of long-term effects in daily life.
The same molecule can do opposite things. GnRH signaling is famously sensitive to rhythm: pulsed stimulation switches the reproductive axis on, while constant stimulation can switch it down. Research on kisspeptin has raised the same question about continuous exposure. It is one reason the timing and pattern of the signal get so much attention in the scientific literature.
Other research directions
Kisspeptin is studied well beyond the brain-imaging work. Clinical researchers have investigated it in fertility medicine, including as a potential trigger for the final maturation of eggs during IVF, and as a diagnostic tool for telling apart different causes of delayed puberty. Its original role as a possible suppressor of cancer spread is still studied as well.
Where it stands
- Approval: kisspeptin is not an approved drug for any use.
- Regulatory: kisspeptin-10 was one of twelve peptides removed from the FDA's restricted compounding list in April 2026, which reopened review rather than granting approval. It was not among the compounds recommended by the FDA's advisory committee in July 2026. The background is in The FDA "Peptide Ban" of 2026.
- Evidence tier: on PUŪRA's A–E evidence ladder, kisspeptin sits at C: controlled human studies exist, mostly small, short and using the longer kisspeptin-54 form, with no approval behind them.
The takeaway
Kisspeptin's nicknames are better earned than most. It genuinely sits at the top of the reproductive chain, and placebo-controlled human studies have linked it to sexual and emotional processing in the brain. The details are what separate the science from the shorthand: which form was studied, how it was given, for how long, and what was actually measured.
Frequently asked questions
What is kisspeptin?
Kisspeptin is a natural hormone produced by nerve cells in the hypothalamus. It activates the kisspeptin receptor and triggers the release of GnRH, which sets the whole reproductive hormone chain in motion.
Why is kisspeptin called the master switch of reproduction?
Because it sits upstream of every other reproductive hormone. In 2003 researchers found that people and mice without a working kisspeptin receptor do not go through puberty, showing the reproductive axis cannot switch on without its signal.
Why is it called kisspeptin?
The gene was discovered in 1996 by researchers in Hershey, Pennsylvania, and named KiSS-1 as a nod to Hershey's Kisses chocolates.
What is the difference between kisspeptin-10 and kisspeptin-54?
Kisspeptin-54 is a 54-amino-acid form of the hormone. Kisspeptin-10 is its final ten amino acids. Both activate the same receptor, but kisspeptin-10 is cleared from the blood much faster. The Imperial College studies on sexual and emotional brain processing used kisspeptin-54.
Is kisspeptin FDA approved?
No. Kisspeptin is not approved for any use. It has been studied in controlled human trials, mostly small and short-term, in reproductive medicine and brain-imaging research.